Back to Journals » Infection and Drug Resistance » Volume 3 » default

Infection and Drug Resistance


Archive: Volume 3, 2010

Current strategies for the prevention and management of central line-associated bloodstream infections

Zhuolin Han, Stephen Y Liang, Jonas Marschall

Infection and Drug Resistance 2010, 3:147-163

Published Date: 23 November 2010

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis

Martha K Daddario, Jennifer K Hagerman, Michael E Klepser

Infection and Drug Resistance 2010, 3:123-132

Published Date: 28 October 2010

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al

Infection and Drug Resistance 2010, 3:115-122

Published Date: 22 October 2010

Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

Charlotte Charpentier, Laurence Weiss

Infection and Drug Resistance 2010, 3:103-114

Published Date: 13 October 2010

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens

Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.

Infection and Drug Resistance 2010, 3:95-101

Published Date: 30 August 2010

Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al

Infection and Drug Resistance 2010, 3:87-94

Published Date: 19 August 2010

Methicillin-resistant Staphylococcus aureus in HIV-infected patients

Alicia I Hidron, Russell Kempker, Abeer Moanna, et al

Infection and Drug Resistance 2010, 3:73-86

Published Date: 6 August 2010

The use of anti-tuberculosis therapy for latent TB infection

Justin T Denholm, Emma S McBryde

Infection and Drug Resistance 2010, 3:63-72

Published Date: 21 July 2010

Role of posaconazole in the treatment of oropharyngeal candidiasis

Voichita Ianas, Kathryn R Matthias, Stephen A Klotz

Infection and Drug Resistance 2010, 3:45-51

Published Date: 28 June 2010

Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial

Lorenzo Aguilar, María-José Giménez, José Barberán

Infection and Drug Resistance 2010, 3:35-43

Published Date: 18 June 2010

Emerging agents to combat complicated and resistant infections: focus on ceftobiprole

César Bustos, Jose L Del Pozo

Infection and Drug Resistance 2010, 3:5-14

Published Date: 22 April 2010

Respiratory failure caused by intrathoracic amoebiasis

Toshinobu Yokoyama, Masashi Hirokawa, Yutaka Imamura, et al

Infection and Drug Resistance 2010, 3:1-4

Published Date: 11 March 2010